TherapeuticsMD, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-76.9M | $-89.9M | $-85.1M | $-54.2M | $-28.4M | $-35.1M | $-12.9M |
| Depreciation & Amortization | $213.1K | $132.5K | $62.4K | $52.5K | $58.1K | $56.3K | $54.8K |
| Depreciation | $141.6K | $77.9K | $30.0K | $29.0K | $47.9K | $27.5K | $25.7K |
| Amortization | $71.5K | $54.5K | $32.4K | $23.5K | $10.3K | $28.8K | $29.2K |
| Stock-Based Compensation | $6.9M | $17.4M | $7.2M | $5.0M | $3.8M | $1.9M | $190.5K |
| Net Cash from Operating Activities | $-76.2M | $-69.1M | $-79.0M | $-45.5M | $-20.8M | $-12.7M | $-5.0M |
| Investing Activities | |||||||
| Capital Expenditures | $61.8K | $396.2K | $165.3K | $31.0K | $40.8K | $66.4K | $28.8K |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-827.1K | $-1.3M | $-584.4K | $-606.8K | $-583.6K | $-272.5K | $-37.6K |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $72.6M | $137.2M | $93.0M | $43.3M | $74.0M | $14.4M | $4.7M |
| Net Change in Cash | — | — | — | — | — | — | — |
| Free Cash Flow | $-76.2M | $-69.5M | $-79.2M | $-45.6M | $-20.8M | $-12.8M | $-5.0M |